Search
for
Sort by
Research 181–210 of 345
- Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
- A rash diagnosis
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Safety Evaluation of Topical Valproate Application
- “PRIDE” Complex
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- Beau’s Lines and COVID-19; A Systematic Review on Their Association
- Rare and common manifestations of COVID‐19 in children
- Skin Manifestations of Rheumatological Diseases
- Enanthem in Patients With COVID-19 and Skin Rash
- COVID‐19 and dermatology: a comprehensive guide for dermatologists
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Demodicosis in Different Age Groups and Alternative Treatment Options—A Review
- Nonhuman primate dermatology: a literature review
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- Dermatological Manifestations of COVID-19 in Children
- Contributions of dermatologists to COVID ‐19 research: A brief systematic review
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Circle Hairs in a Patient with Multiple Myeloma
- Factors Associated with Acute Telogen Effluvium and COVID-19 Infection
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Secondary Syphilis in Cali, Colombia: New Concepts in Disease Pathogenesis
- What's new in the pathogeneses and triggering factors of bullous pemphigoid